To our knowledge, this is the first large consecutive cohort focused on HER2-negative breast cancer population to systematically explore the accuracy of IHC/FISH or qRT-PCR methods to detect the HER2-low expression and define the optimal HER2-low breast tumors. This evidence concerns the gene ERBB2 and breast cancer.